Direct-to-consumer rapamycin protocols: a regulatory and clinical analysis

Editorial framing of the social-media rapamycin protocols as outpacing the safety surveillance.

• 01Design: Editorial — weighted accordingly in our rubric.
• 02Notable limitations — confounding, sample size, or short follow-up.
• 03Effect direction is consistent with adjacent literature in our index.

Native comments, Twitter mentions, and Reddit threads about this paper — surfaced together so the conversation isn't fragmented across platforms.